Rx Cost-Effectiveness Studies Should Be Part Of Medicare Bill, AARP Says
Executive Summary
AARP wants the House/Senate Medicare conference committee to include a provision mandating federal cost-effectiveness research on pharmaceuticals
You may also be interested in...
AARP Wants HHS Price Negotiation If Medicare Discounts Are Insufficient
AARP would work to give HHS negotiating authority on Medicare drug prices if discounts negotiated by private plans and manufacturers are inadequate
AARP Wants HHS Price Negotiation If Medicare Discounts Are Insufficient
AARP would work to give HHS negotiating authority on Medicare drug prices if discounts negotiated by private plans and manufacturers are inadequate
Rx Cost-Effectiveness Beyond Medicare: Merck, AARP Plan Policy Meeting
Merck and AARP are working with the Agency for Healthcare Research & Quality to organize a "stakeholders" meeting to discuss standards for cost-effectiveness research